Ectopic EZH2 expression increased the sphere formation ability of ovarian cancer cells, whereas EZH2 downregulation in CSCs reduced self-renewal, chemotherapy resistance and tumor-initiating capacity. Here, EZH2 is linked to ovarian carcinoma.